Tibet AIM Pharm Balance Sheet Health
Financial Health criteria checks 6/6
Tibet AIM Pharm has a total shareholder equity of CN¥738.8M and total debt of CN¥8.3M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are CN¥953.5M and CN¥214.7M respectively. Tibet AIM Pharm's EBIT is CN¥52.1M making its interest coverage ratio -13.7. It has cash and short-term investments of CN¥387.9M.
Key information
1.1%
Debt to equity ratio
CN¥8.28m
Debt
| Interest coverage ratio | -13.7x |
| Cash | CN¥387.89m |
| Equity | CN¥738.76m |
| Total liabilities | CN¥214.72m |
| Total assets | CN¥953.48m |
Recent financial health updates
No updates
Recent updates
What Tibet AIM Pharm. Inc.'s (SZSE:002826) 28% Share Price Gain Is Not Telling You
Nov 26
Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality
Nov 06Some Confidence Is Lacking In Tibet AIM Pharm. Inc.'s (SZSE:002826) P/E
Jun 07Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality
May 02Risks Still Elevated At These Prices As Tibet AIM Pharm. Inc. (SZSE:002826) Shares Dive 26%
Feb 29Financial Position Analysis
Short Term Liabilities: 002826's short term assets (CN¥524.7M) exceed its short term liabilities (CN¥208.7M).
Long Term Liabilities: 002826's short term assets (CN¥524.7M) exceed its long term liabilities (CN¥6.0M).
Debt to Equity History and Analysis
Debt Level: 002826 has more cash than its total debt.
Reducing Debt: 002826's debt to equity ratio has reduced from 11.2% to 1.1% over the past 5 years.
Debt Coverage: 002826's debt is well covered by operating cash flow (2447%).
Interest Coverage: 002826 earns more interest than it pays, so coverage of interest payments is not a concern.